{"abstract":"The Drug Enforcement Administration proposes placing N-(1-(2- fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide (2'- fluoro ortho-fluorofentanyl), N-(1-(4-methylphenethyl)piperidin-4-yl)- N-phenylacetamide (4'-methyl acetyl fentanyl), N-(1-phenethylpiperidin- 4-yl)-N,3-diphenylpropanamide ([beta]'-phenyl fentanyl; 3- phenylpropanoyl fentanyl), N-phenyl-N-(1-(2-phenylpropyl)piperidin-4- yl)propionamide ([beta]-methyl fentanyl), N-(2-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)butyramide (ortho-fluorobutyryl fentanyl; 2- fluorobutyryl fentanyl), N-(2-methylphenyl)-N-(1-phenethylpiperidin-4- yl)acetamide (ortho-methyl acetylfentanyl; 2-methyl acetylfentanyl), 2- methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide (ortho-methyl methoxyacetylfentanyl), N-(4-methylphenyl)-N-(1- phenethylpiperidin-4-yl)propionamide (para-methylfentanyl; 4- methylfentanyl), N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide (phenyl fentanyl; benzoyl fentanyl), N-(1-phenethylpiperidin-4-yl)-N- phenylthiophene-2-carboxamide (thiofuranyl fentanyl), including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, in schedule I of the Controlled Substances Act. These ten specific substances fall within the definition of fentanyl-related substances set forth in the February 6, 2018, temporary scheduling order. Through the Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act, which became law on February 6, 2020, Congress extended the temporary control of fentanyl-related substances until May 6, 2021. If finalized, this action would make permanent the existing regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle 2'- fluoro ortho-fluorofentanyl, 4'-methyl acetyl fentanyl, [beta]'-phenyl fentanyl, [beta]-methyl fentanyl, ortho-fluorobutyryl fentanyl, ortho- methyl acetylfentanyl, ortho-methyl methoxyacetyl fentanyl, para- methylfentanyl, phenyl fentanyl, and thiofuranyl fentanyl.","action":"Notice of proposed rulemaking.","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2021/03/03/2021-04214.html","cfr_references":[{"chapter":null,"citation_url":null,"part":"1308","title":21}],"citation":"86 FR 12296","comment_url":null,"comments_close_on":"2021-04-02","correction_of":null,"corrections":[],"dates":"Comments must be submitted electronically or postmarked on or before April 2, 2021.","disposition_notes":null,"docket_ids":["Docket No. DEA-476"],"dockets":[{"supporting_documents":[{"title":"Signed OASH Letter to DEA with Review 02Jul20","document_id":"DEA-2021-0006-0003"},{"title":"DEA Eight-Factor Analysis for 10 FRS","document_id":"DEA-2021-0006-0002"}],"agency_name":"DEA","documents":[{"comment_count":11,"comment_start_date":"2021-03-03","updated_at":"2023-02-28T13:05:57.106-05:00","comment_url":"https://www.regulations.gov/commenton/DEA-2021-0006-0001","allow_late_comments":null,"id":"DEA-2021-0006-0001","comment_end_date":"2021-04-03","regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":2,"id":"DEA-2021-0006","title":"Schedules of Controlled Substances: Placement of 10 Specific Fentanyl-Related Substances into Schedule I"}],"document_number":"2021-04214","effective_on":null,"end_page":12305,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2021/03/03/2021-04214.xml","html_url":"https://www.federalregister.gov/documents/2021/03/03/2021-04214/schedules-of-controlled-substances-placement-of-10-specific-fentanyl-related-substances-in-schedule","images":{"EP03MR21.102":{"large":"https://img.federalregister.gov/EP03MR21.102/EP03MR21.102_large.png","original_size":"https://img.federalregister.gov/EP03MR21.102/EP03MR21.102_original_size.png"}},"images_metadata":{"EP03MR21.102":{"large":{"identifier":"EP03MR21.102","content_type":"image/png","size":14458,"width":823,"sha":"f4288311d11c5c8b10a6f8dd9b901261","url":"https://img.federalregister.gov/EP03MR21.102/EP03MR21.102_large.png","height":431},"original_size":{"identifier":"EP03MR21.102","content_type":"image/png","size":7624,"width":1802,"sha":"95725383e8f5ac25294c40b7b6159e80","url":"https://img.federalregister.gov/EP03MR21.102/EP03MR21.102_original_size.png","height":944}}},"json_url":"https://www.federalregister.gov/api/v1/documents/2021-04214?publication_date=2021-03-03","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2021-03-03/2021-04214/mods.xml","not_received_for_publication":null,"page_length":10,"page_views":{"count":756,"last_updated":"2026-07-27 20:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2021-03-03/pdf/2021-04214.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2021-04214.pdf?1614692724","publication_date":"2021-03-03","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2021/03/03/2021-04214.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[{"title":"Signed OASH Letter to DEA with Review 02Jul20","document_id":"DEA-2021-0006-0003"},{"title":"DEA Eight-Factor Analysis for 10 FRS","document_id":"DEA-2021-0006-0002"}],"comments_count":11,"agency_id":"DEA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=DEA-2021-0006","supporting_documents_count":2,"docket_id":"DEA-2021-0006","document_id":"DEA-2021-0006-0001","regulation_id_number":null,"title":"Schedules of Controlled Substances: Placement of 10 Specific Fentanyl-Related Substances into Schedule I","checked_regulationsdotgov_at":"2023-02-28T18:05:56Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":12296,"subtype":null,"title":"Schedules of Controlled Substances: Placement of 10 Specific Fentanyl-Related Substances in Schedule I","toc_doc":"Placement of 10 Specific Fentanyl-Related Substances in Schedule I","toc_subject":"Schedules of Controlled Substances:\n","topics":["Administrative practice and procedure","Drug traffic control","Reporting and recordkeeping requirements"],"type":"Proposed Rule","volume":86}